IMUX
Immunic Inc

12,394
Mkt Cap
$79.94M
Volume
995,133.00
52W High
$1.39
52W Low
$0.561
PE Ratio
-0.77
IMUX Fundamentals
Price
$0.6646
Prev Close
$0.6883
Open
$0.6883
50D MA
$0.7903
Beta
1.61
Avg. Volume
1.22M
EPS (Annual)
-$1.00
P/B
6.24
Rev/Employee
$0.00
Loading...
Loading...
News
all
press releases
Immunic to Participate in the 8th Annual Evercore ISI Healthcare Conference in December
Immunic to Participate in the 8th Annual Evercore ISI Healthcare Conference in December Immunic to Participate in the 8th Annual Evercore ISI Healthcare Conference in December PR Newswire NEW YORK...
PR Newswire·10d ago
News Placeholder
More News
News Placeholder
Analysts Offer Predictions for Immunic FY2025 Earnings
Immunic, Inc. (NASDAQ:IMUX - Free Report) - Investment analysts at Chardan Capital issued their FY2025 earnings per share estimates for Immunic in a research note issued to investors on Wednesday...
MarketBeat·13d ago
News Placeholder
Equities Analysts Issue Forecasts for Immunic Q1 Earnings
Immunic, Inc. (NASDAQ:IMUX - Free Report) - Investment analysts at Brookline Capital Management issued their Q1 2026 earnings estimates for shares of Immunic in a research report issued to clients...
MarketBeat·15d ago
News Placeholder
HC Wainwright Cuts Immunic (NASDAQ:IMUX) Price Target to $8.00
HC Wainwright lowered their target price on shares of Immunic from $10.00 to $8.00 and set a "buy" rating for the company in a research note on Friday...
MarketBeat·21d ago
News Placeholder
Immunic (NASDAQ:IMUX) Issues Quarterly Earnings Results, Beats Expectations By $0.05 EPS
Immunic (NASDAQ:IMUX - Get Free Report) released its quarterly earnings results on Thursday. The company reported ($0.13) EPS for the quarter, beating the consensus estimate of ($0.18) by $0.05...
MarketBeat·22d ago
News Placeholder
D. Boral Capital Cuts Immunic (NASDAQ:IMUX) Price Target to $8.00
D. Boral Capital reduced their target price on Immunic from $10.00 to $8.00 and set a "buy" rating for the company in a report on Thursday...
MarketBeat·22d ago
News Placeholder
Immunic, Inc. Reports Third Quarter 2025 Financial Results and Provides Corporate Update
Immunic, Inc. Reports Third Quarter 2025 Financial Results and Provides Corporate Update Immunic, Inc. Reports Third Quarter 2025 Financial Results and Provides Corporate Update PR Newswire NEW YORK...
PR Newswire·23d ago
News Placeholder
Q3 Earnings Forecast for Immunic Issued By Roth Capital
Immunic, Inc. (NASDAQ:IMUX - Free Report) - Equities researchers at Roth Capital issued their Q3 2025 EPS estimates for Immunic in a research report issued on Friday, November 7th. Roth Capital...
MarketBeat·27d ago
News Placeholder
Immunic (NASDAQ:IMUX) Now Covered by Analysts at Roth Capital
Roth Capital began coverage on Immunic in a report on Friday. They issued a "buy" rating and a $3.00 price target on the stock...
MarketBeat·28d ago
News Placeholder
Immunic to Participate in Industry and Investor Conferences in November
Immunic to Participate in Industry and Investor Conferences in November Immunic to Participate in Industry and Investor Conferences in November PR Newswire NEW YORK, Oct. 29, 2025 NEW YORK, Oct. 29...
PR Newswire·1mo ago

Latest IMUX News

View

Advertisement|Remove ads.

Advertisement|Remove ads.